SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-000815
Filing Date
2022-01-12
Accepted
2022-01-12 16:51:41
Documents
14
Period of Report
2022-01-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20220111.htm   iXBRL 8-K 40881
2 EX-99.1 exhibit991preliminaryresul.htm EX-99.1 17940
6 imagea.jpg GRAPHIC 21590
  Complete submission text file 0001628280-22-000815.txt   239962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20220111.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20220111_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20220111_pre.xml EX-101.PRE 13582
8 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20220111_htm.xml XML 11963
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 22527054
SIC: 3841 Surgical & Medical Instruments & Apparatus